Chido-Amajuoyi Onyema Greg, Mantey Dale S, Omega-Njemnobi Onyinye, Yu Robert K, Shete Sanjay
Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Department of Health Promotion and Behavioral Science, University of Texas School of Public Health, Austin, TX, United States.
Addict Behav. 2021 Apr;115:106790. doi: 10.1016/j.addbeh.2020.106790. Epub 2020 Dec 30.
There is an established link between depression and tobacco use among adults; however, to date, research has not explored the association of use of dual/poly tobacco products with symptoms and use of medication for depression.
Data were derived from a 2018 Texas population health assessment survey (n = 2034). Multivariable logistic and multinomial regressions were used to examine for associations between self-reported symptoms of depression and use of prescription medications for depression with use of dual/poly tobacco products.
About 20% of adults used one tobacco product, while 9.7% used two or more products. Compared to those without depressive symptoms, those with depressive symptoms had greater odds of single (aOR: 1.66, 95% CI; 1.21 - 2.29) or dual/poly (aOR: 3.09, 95% CI; 1.92 - 4.96) tobacco product use relative to non-users; and relative to single product use, those with depressive symptoms had greater odds of dual/poly tobacco product use (aOR: 2.07; 95% CI, 1.30 - 3.32). Compared to those not using medication for depression, use of medication for depression was associated with a 1.80 (95% CI: 1.15 - 2.84) greater odds of dual/poly tobacco product use relative to non-users; and a 1.91 (95% CI: 1.14 - 3.19) greater odds of dual/poly product use relative to single product users.
Study findings call for primary care providers and psychiatrists to expand screening of individuals experiencing depressive symptoms and using medication for depression, to include assessment for dual/poly tobacco product use.
成年人中抑郁症与烟草使用之间的联系已得到证实；然而，迄今为止，研究尚未探讨使用双重/多种烟草产品与抑郁症症状及抗抑郁药物使用之间的关联。
数据来源于2018年德克萨斯州人口健康评估调查（n = 2034）。采用多变量逻辑回归和多项回归分析，以检验自我报告的抑郁症症状及抗抑郁药物使用与双重/多种烟草产品使用之间的关联。
约20%的成年人使用一种烟草产品，而9.7%的成年人使用两种或更多种产品。与没有抑郁症状的人相比，有抑郁症状的人使用单一烟草产品（调整后比值比：1.66，95%置信区间；1.21 - 2.29）或双重/多种烟草产品（调整后比值比：3.09，95%置信区间；1.92 - 4.96）的几率相对于不使用者更高；相对于单一产品使用，有抑郁症状的人使用双重/多种烟草产品的几率更高（调整后比值比：2.07；95%置信区间，1.30 - 3.32）。与未使用抗抑郁药物的人相比，使用抗抑郁药物与双重/多种烟草产品使用几率相对于不使用者高出1.80（95%置信区间：1.15 - 2.84）；相对于单一产品使用者，双重/多种产品使用几率高出1.91（95%置信区间：1.14 - 3.19）。
研究结果呼吁初级保健提供者和精神科医生扩大对有抑郁症状且正在使用抗抑郁药物的个体的筛查，包括对双重/多种烟草产品使用情况的评估。
